Skip to Content
Merck
CN

HKI4MAG-99K

MILLIPLEX® Human Kidney Injury Panel

Configurable Human Kidney Toxicity 7-plex Panel 4

Sign In to View Organizational & Contract Pricing.

About This Item

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

MILLIPLEX® Human Kidney Injury Panel,

species reactivity

human

Quality Level

description

Configurable Human Kidney Toxicity 7-plex Panel 4

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

accuracy: 63-118%, intra-assay cv: <10, sensitivity: 0.01-0.71 ng/mL
(MinDC+2SD), standard curve range: 0.01-5 ng/mL
(IP-10), standard curve range: 0.012-12.5 ng/mL
(EGF), standard curve range: 0.02-20 ng/mL
(PTH), standard curve range: 0.15-150 ng/mL
(FABP1), standard curve range: 0.17-1,200 ng/mL
(Osteopontin (OPN)), standard curve range: 0.20-200 ng/mL
(KIM-1), standard curve range: 0.68-700 ng/mL
(Renin)

technique(s)

multiplexing: suitable

input

serum

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

Looking for similar products? Visit Product Comparison Guide

General description

Albumin, Beta-2 Microglobulin, Clusterin, Cystatin C, and Lipocalin-2/NGAL are important biomarkers for evaluating kidney function, tubular integrity, and early signs of renal injury. These analytes help detect glomerular filtration changes, proteinuria, and inflammation, making them valuable for monitoring acute and chronic kidney conditions. Their combined assessment supports sensitive and specific evaluation of renal health.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 7 analytes in human serum or plasma samples.

Analytes included: α-1-Microglobulin, Albumin, Clusterin, Cystatin C, EGF, Lipocalin-2/NGAL, Osteopontin (OPN)

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

Features:


  • Measures 7 key biomarkers of kidney injury in human urine samples

  • Includes α-1-Microglobulin, Albumin, Clusterin, Cystatin C, EGF, Lipocalin-2/NGAL, and Osteopontin (OPN)

  • Magnetic bead-based format for enhanced precision and simplified washing

  • Utilizes Luminex® xMAP® technology for multiplexing and high-throughput analysis

  • Validated for human urine with recommended sample dilution of 1:100

  • Assay sensitivity ranges from 0.015 to 5.359 ng/mL depending on the analyte

  • Standard curve ranges from 0.01 to 5,000 ng/mL across analytes

  • Intra-assay CV < 10%, inter-assay CV < 20%
Benefits:

  • Enables early and specific detection of kidney injury before traditional markers like BUN and serum creatinine



  • Provides insight into organ-specific damage and mechanisms of nephrotoxicity

  • Conserves sample volume by analyzing multiple biomarkers in a single run

  • Supports drug safety and toxicity research with high analytical performance

  • Reduces assay variability and improves reproducibility across studies

  • Compatible with both manual and automated workflows for flexible lab integration

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

Regulatory Information

新产品
This item has

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Annie Moisan et al.
Molecular therapy. Nucleic acids, 6, 89-105 (2017-03-23)
Antisense oligonucleotide (AON) therapeutics offer new avenues to pursue clinically relevant targets inaccessible with other technologies. Advances in improving AON affinity and stability by incorporation of high affinity nucleotides, such as locked nucleic acids (LNA), have sometimes been stifled by

Related Content

Multiplex toxicity assays enable researchers to simultaneously measure multiple toxicity biomarkers of various organs to gain a better understanding of toxicity. Explore how MILLIPLEX® multiplex toxicity assays are advancing research on liver injury, kidney toxicity, genotoxicity, and more.

Novel kidney toxicity biomarkers expand options for acute nephrotoxicity detection. Multiplex assays measure multiple renal damage biomarkers in small sample volumes, minimizing time and costs. See how MILLIPLEX® multiplex kidney toxicity assays detected vancomycin-induced subacute nephrotoxicity in rat models.

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service